The realm of respiratory health has undergone significant transformation with the advent of mucolytic agents like Mucosant, designed to combat the challenges posed by excessive mucus production in conditions such as respiratory infections, cystic fibrosis, and chronic obstructive pulmonary disease (COPD). It represents more than just a treatment option; it embodies a convergence of cutting-edge […]